A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01949883
Recruitment Status : Active, not recruiting
First Posted : September 25, 2013
Last Update Posted : February 2, 2018
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Constellation Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : December 2017
  Estimated Study Completion Date : July 2018